Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
Simonin M, Schmidt A, Bontoux C, Dourthe MÉ, Lengliné E, Andrieu GP, Lhermitte L, Graux C, Grardel N, Cayuela JM, Huguet F, Arnoux I, Ducassou S, Macintyre E, Gandemer V, Dombret H, Petit A, Ifrah N, Baruchel A, Boissel N, Asnafi V.
Simonin M, et al. Among authors: schmidt a.
J Hematol Oncol. 2021 May 3;14(1):74. doi: 10.1186/s13045-021-01068-4.
J Hematol Oncol. 2021.
PMID: 33941203
Free PMC article.